MC
BSX icon

Mirabaud & Cie’s Boston Scientific BSX Stock Holding History

Mirabaud & Cie’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,784
Closed -$237K – 55
2026
Q1 		$237K Buy
+3,784
New +$303K 0.1% 51
2024
Q4 		– Sell
-17,740
Closed -$1.49M – 62
2024
Q3 		$1.49M Buy
+17,740
New +$1.4M 0.43% 38

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Mirabaud & Cie's BSX Position: Q2 2026 in Review

Mirabaud & Cie sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,784 shares — an estimated $237K sold.

Mirabaud & Cie first reported a position in BSX in Q3 2024 and held it in 2 quarters. The position peaked at $1.49M in Q3 2024. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mirabaud & Cie reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Mirabaud & Cie sold 3,784 Boston Scientific shares in Q2 2026, an estimated $237K.
  • Mirabaud & Cie first reported a position in Boston Scientific in Q3 2024 and held it in 2 quarters.
  • Mirabaud & Cie's Boston Scientific position peaked at $1.49M in Q3 2024.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mirabaud & Cie's 13F filing for Q2 2026, filed 8 Jul 2026.